BCM
TMCI icon

Bronte Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Bronte Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62K Buy
+15,577
New +$42.8K 0.01% 42

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bronte Capital Management's TMCI Position: Q2 2026 in Review

Bronte Capital Management opened a new position in Treace Medical Concepts (TMCI) in Q2 2026: 15,577 shares worth $62K. The stake represents 0.01% of the portfolio and ranks #42 among its holdings.

117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Bronte Capital Management held 15,577 shares of Treace Medical Concepts worth $62K as of Q2 2026.
  • Treace Medical Concepts was a new Bronte Capital Management position in Q2 2026.
  • Treace Medical Concepts made up 0.01% of Bronte Capital Management's portfolio in Q2 2026, its #42 holding.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Bronte Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.